학술논문
230 (PB110) - Efficacy signals, long-term exposure and safety data from a phase 1–2 study of a cell-penetrating peptide antagonist of CEBPβ, a novel target, in patients (pts) with refractory solid tumors
Document Type
Abstract
Author
Source
In European Journal of Cancer October 2022 174 Supplement 1:S82-S83
Subject
Language
ISSN
0959-8049